FDA inspection
CMC Pharmaceuticals, Inc.: FDA inspection ending Sep 27, 2023
FDA inspection 1219626 · No Action Indicated (NAI) · Solon, OH
Key facts
| Inspection ID | 1219626 |
|---|---|
| Firm | CMC Pharmaceuticals, Inc. |
| FEI number | 3015119969 |
| Address | 30625 Solon Rd Unit G |
| City | Solon |
| State | OH |
| ZIP | 44139 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Sep 27, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data